Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/31/1994 | WO1994006932A1 A process of quantifying cell number |
03/31/1994 | WO1994006919A2 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
03/31/1994 | WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
03/31/1994 | WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides |
03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
03/31/1994 | WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis |
03/31/1994 | WO1994006826A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
03/31/1994 | WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
03/31/1994 | WO1994006812A1 Green fluorescent labeled nucleotides for use in probes |
03/31/1994 | WO1994006745A1 Method for making valproic acid derivatives |
03/31/1994 | WO1994006474A1 ANTIBODY TREATMENT OF $i(HELICOBACTER PYLORI) |
03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
03/31/1994 | WO1994006463A1 Immortalized cells and uses therefor |
03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
03/31/1994 | WO1994006345A2 Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof |
03/31/1994 | WO1994006290A1 Preserved, non-infectious control cells for use in the identification of a disease through blood testing |
03/31/1994 | WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases |
03/31/1994 | WO1994003602A3 A novel human dopamine receptor and its uses |
03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
03/31/1994 | DE4333320A1 Asphalt sampler assembly minimising health risks and maximising solvent recovery and reuse - with sieve tower either in solvent sepn. and recovery unit circuit, or in drying assembly flow circuit |
03/31/1994 | DE4331881A1 Automated analyser for blood coagulation tests - includes a carousel holding numerous modules, each contg. a test cell and fitted with system for detecting scattered light |
03/31/1994 | DE4232528A1 Quantitative determination of degree of hardening of lacquer layers pref. on optical fibres - by solvent extracting layer then chromatographically separating unreacted monomer and determining monomer content by UV spectroscopy |
03/31/1994 | DE4232509A1 Measuring contaminants in containers,e.g. plastic bottles - involves using mass spectrometer with ionisation and photon stimulation |
03/31/1994 | DE4232281C1 Determining substance concn. in environment - by measuring effects on plants, to determine pollutant concn. or optimal plant culture conditions |
03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
03/31/1994 | CA2145389A1 Quantitative measurement of ldl |
03/31/1994 | CA2145092A1 Conjugate for the detection and/or assay of a biological compound |
03/31/1994 | CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis |
03/31/1994 | CA2144742A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
03/31/1994 | CA2144651A1 Immortalized cells and uses therefor |
03/31/1994 | CA2144511A1 Methods and kits for evaluating risk of developing periodontitis |
03/31/1994 | CA2144435A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
03/31/1994 | CA2143945A1 A method for the detection and treatment of prostate disease |
03/31/1994 | CA2143764A1 Self-confirming assay devices |
03/31/1994 | CA2143758A1 Preserved, non-infectious control cells for use in the identification of a disease through blood testing |
03/31/1994 | CA2122816A1 Method for making valproic acid derivatives |
03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
03/30/1994 | EP0589772A1 Plate apparatus for mechanical testing of soils and vehicle equipped with this apparatus |
03/30/1994 | EP0589636A1 Magnetic separation method |
03/30/1994 | EP0589612A2 Label trapping, nonseparation binding assay |
03/30/1994 | EP0589556A2 Carbohydrate-based anti-inflammatory agents |
03/30/1994 | EP0589546A2 Apparatus for measuring the total organic carbon and nitrogen content of water |
03/30/1994 | EP0589503A1 Hydrogen sulfide gas sensor and precursor compounds for manufacture of same |
03/30/1994 | EP0589487A1 Monoclonal antibodies for small organic molecules |
03/30/1994 | EP0589384A2 Method for determining experimentally the parameters for optimal results |
03/30/1994 | EP0589372A2 Method of detecting liquids in fibrous and/or porous materials |
03/30/1994 | EP0589348A2 Method for immunological quantification of inactivated antigenes |
03/30/1994 | EP0589011A1 METHOD FOR THE DETERMINATION OF PLASMIN/$g(a)2-ANTIPLASMIN COMPLEXES AND THE USE OF THIS METHOD AS A MEAN OF DETERMINING CHANGES IN THE FIBRINOLYTIC SYSTEM |
03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
03/30/1994 | EP0589001A1 Determination of glycated hemoglobin by fluorescence quenching |
03/30/1994 | EP0588972A1 Optical imaging for positioning and cell counting |
03/30/1994 | EP0588969A1 Optical imaging for agglutination detection |
03/30/1994 | EP0588968A1 Liquid dispensing mechanism |
03/30/1994 | EP0588967A1 Multiple reaction well cartridge |
03/30/1994 | EP0588958A1 Assay for the detection of specific ligands |
03/30/1994 | EP0588931A1 Automated specimen analyzing apparatus and method |
03/30/1994 | EP0588903A1 Soluble hla cross-match |
03/30/1994 | EP0588891A1 Method and sensor means for determining myocardial infarction markers |
03/30/1994 | EP0588866A1 Device for determining the foaming properties of an at least partially soluble material. |
03/30/1994 | EP0588844A1 Improvements in or relating to centrifuges and associated apparatus and methods. |
03/30/1994 | EP0588831A1 Analytical methods |
03/30/1994 | EP0539456B1 Device for continuously detecting contrast impurities contained in a moving fluid material |
03/30/1994 | EP0329794B1 Method for assaying human lung surface active substance |
03/30/1994 | CN1084638A Test method for determining thinness of textile fibre by the method o twice axial compressed air-flow |
03/29/1994 | US5299319 High performance interlock collapsing SCISM ALU apparatus |
03/29/1994 | US5299141 Automatic fluid monitoring and sampling apparatus and method |
03/29/1994 | US5299140 Means and method for measurement of porous materials |
03/29/1994 | US5298860 Method of analyzing metal impurities in surface oxide film of semiconductor substrate |
03/29/1994 | US5298783 Combined semiconductor gas sensor |
03/29/1994 | US5298605 Diabetes |
03/29/1994 | US5298599 Fusion protein |
03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
03/29/1994 | US5298583 Polymer dyestuffs and preparation and use thereof |
03/29/1994 | US5298522 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
03/29/1994 | US5298491 Analytical kit |
03/29/1994 | US5298490 Tetra and penta-peptides useful in regulating the immune system |
03/29/1994 | US5298430 Molded and compressed into predetermined shape |
03/29/1994 | US5298429 Monitoring transcription of reporter gene |
03/29/1994 | US5298427 Chemiluminescent detection of amino acids |
03/29/1994 | US5298426 Method of differentiating erythroblasts from other cells by flow cytometry |
03/29/1994 | US5298419 Diagnosis |
03/29/1994 | US5298407 DNA encoding a protein active in lymphocyte-mediated cytotoxicity |
03/29/1994 | US5298406 Formulation for stabilizing enzymatic activity and immunoreactivity of creatine kinase and creatine kinase isoenzymes |
03/29/1994 | US5298403 Labeled drug hapten analogues for immunoassays |
03/29/1994 | US5298401 Process for the quantitative determination of the function and antigenic concentration of a substance contained in a biological liquid |
03/29/1994 | US5298400 Genetic engineering and gene expression |
03/29/1994 | US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase |
03/29/1994 | US5298396 Exposure to superantigen and detecting a form of the T-cell antigen receptor |
03/29/1994 | US5298395 Hyperglycosylated cytokine conjugates |
03/29/1994 | US5298394 Antigen-antibody reaction |
03/29/1994 | US5298393 Monoclonal antibody for human acid-glutathione S-transferase and process for preparation thereof |
03/29/1994 | US5298392 Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor |
03/29/1994 | US5298391 Use of the SP-2 monoclonal antibody for the clinical diagnostics and for the monitoring of the HIV infection progress |
03/29/1994 | US5298224 Apparatus for determination of the coagulation time of a blood sample |
03/29/1994 | US5298197 Oil phase consisting fluorescer compound and oxalates, aqueous phase containing oxidizer, and surfactant |
03/29/1994 | US5298146 Device for the simultaneous detection of dissimilar gas components |
03/29/1994 | US5298135 Production of electrophoretically-homogenous protein-colloidal gold complexes |
03/29/1994 | US5298122 Measuring device and method for measuring the crosswise profile of a paper web |